Pfizer logo

Pfizer

North America, New York, United States, New York

Description

Pfizer is a biopharmaceutical company that provides affordable access to safe, effective medicines and health care services.

Investor Profile

Pfizer has made 51 investments, with 2 in the past 12 months and 43% as lead.

Stage Focus

  • Series A (18%)
  • Post Ipo Equity (18%)
  • Series B (12%)
  • Series Unknown (10%)
  • Seed (10%)
  • Corporate Round (10%)
  • Grant (10%)
  • Series C (8%)
  • Series E (2%)
  • Series D (2%)

Country Focus

  • United States (61%)
  • Israel (10%)
  • Switzerland (4%)
  • Belgium (4%)
  • The Netherlands (4%)
  • France (4%)
  • Canada (2%)
  • Sweden (2%)
  • Ireland (2%)
  • Kenya (2%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Medical
  • Biopharma
  • Oncology
  • Life Science
  • Health Diagnostics
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Pfizer frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 3
Sofinnova Investments
North America, California, United States, Menlo Park
Co-Investments: 3
Pfizer Venture Investments
North America, New York, United States, New York
Co-Investments: 3
Canaan Partners
North America, California, United States, Menlo Park
Co-Investments: 4
Alexandria Venture Investments
North America, California, United States, Pasadena
Co-Investments: 2
Bay City Capital
North America, California, United States, San Francisco
Co-Investments: 3
Sphera Global Healthcare Fund
Asia, Tel Aviv, Israel, Tel Aviv
Co-Investments: 3
Revelation Partners
North America, California, United States, San Francisco
Co-Investments: 3
EQT Life Sciences
Europe, Noord-Holland, The Netherlands, Amsterdam
Co-Investments: 3
Takeda Ventures
North America, California, United States, San Diego
Co-Investments: 4

Which angels does Pfizer often collaborate with?

HT
Europe, Noord-Brabant, The Netherlands, Tilburg
Shared Deals: 1

What are some of recent deals done by Pfizer?

RNT Health Insights

Chandigarh, Chandigarh, India

RNT Health Insights is developing SaMD solutions to aid endoscopists in the real-time detection of upper gastrointestinal lesions.

Artificial Intelligence (AI)Computer VisionHealth Diagnostics
GrantNov 11, 2024
Amount Raised: $29,616
CytoReason

Tel Aviv, Tel Aviv, Israel

CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data.

BiopharmaBiotechnologyHealth CareHealth DiagnosticsPharmaceutical
Series BJul 17, 2024
Amount Raised: $80,000,000
EvolveImmune Therapeutics

Branford, Connecticut, United States

EvolveImmune Therapeutics develops a modular biotherapeutics platform specialized in immuno-oncology.

BiotechnologyHealth CareMedicalOncologyTherapeutics
Series UnknownNov 16, 2023
Amount Raised: $37,398,371
AgomAb Therapeutics

Ghent, Oost-Vlaanderen, Belgium

AgomAb Therapeutics is a Company is developing growth factor-mimetic agonistic monoclonal antibodies to regenerate damaged tissues.

BiotechnologyHealth CareTherapeutics
Series COct 11, 2023
Amount Raised: $100,817,696
CellCentric

Cambridge, Cambridgeshire, United Kingdom

CellCentric is a biotechnology company that targets at deubiquitinase (DUB) enzyme for cancer therapy.

BiotechnologyMedicalTherapeutics
Corporate RoundJul 11, 2023
Amount Raised: $25,000,000
Caribou Biosciences

Berkeley, California, United States

Caribou Biosciences is a biotechnology company that develops CRISPR technologies and allogenic cell therapies for oncology.

BiotechnologyHealth CareOncologyTherapeutics
Post Ipo EquityJun 29, 2023
Amount Raised: $25,000,000
Vedanta Biosciences

Cambridge, Massachusetts, United States

Vedanta Biosciences creates microbiome-derived therapies to address immune and infectious diseases by modulating the gut microbiota.

BiotechnologyBusiness DevelopmentMedical
Series EApr 25, 2023
Amount Raised: $106,500,000
ORIC Pharmaceuticals

South San Francisco, California, United States

ORIC Pharmaceuticals is a biopharmaceutical company that develops treatments that target the causes of therapeutic resistance.

BiopharmaBiotechnologyHealth CarePharmaceuticalTherapeutics
Post Ipo EquityDec 21, 2022
Amount Raised: $25,000,000
Carrick Therapeutics

Dublin, Dublin, Ireland

Carrick Therapeutics is a developer of cancer therapeutics intended to transform the way cancer is treated.

BiotechnologyHealth CarePharmaceuticalTherapeutics
Series CDec 1, 2022
Amount Raised: $60,000,000
CytoReason

Tel Aviv, Tel Aviv, Israel

CytoReason develops a cell-centered computational model of the human body designed to discover complex patterns in biological data.

BiopharmaBiotechnologyHealth CareHealth DiagnosticsPharmaceutical
Corporate RoundSep 20, 2022
Amount Raised: $20,000,000